Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Arjun Adapa"'
Autor:
Siri Sahib S Khalsa, Todd C Hollon, Arjun Adapa, Esteban Urias, Sudharsan Srinivasan, Neil Jairath, Julianne Szczepanski, Peter Ouillette, Sandra Camelo-Piragua, Daniel A Orringer
Publikováno v:
CNS Oncology, Vol 9, Iss 2 (2020)
The discovery of a new mass involving the brain or spine typically prompts referral to a neurosurgeon to consider biopsy or surgical resection. Intraoperative decision-making depends significantly on the histologic diagnosis, which is often establish
Externí odkaz:
https://doaj.org/article/23227fb891224a6c8bc49a555ee23655
Publikováno v:
Journal of Clinical and Translational Science, Vol 5, Pp 91-92 (2021)
ABSTRACT IMPACT: Investigating the relationship between ICH volume at presentation and cortical atrophy over time may help to explain the phenomenon of cognitive impairment after ICH. OBJECTIVES/GOALS: Non-traumatic intracerebral hemorrhage (ICH) is
Externí odkaz:
https://doaj.org/article/03f0b5c43a4f48fba6baca4c9b85bd6d
Autor:
Todd Hollon, Cheng Jiang, Asadur Chowdury, Mustafa Nasir-Moin, Akhil Kondepudi, Alexander Aabedi, Arjun Adapa, Wajd Al-Holou, Jason Heth, Oren Sagher, Pedro Lowenstein, Maria Castro, Lisa Irina Wadiura, Georg Widhalm, Volker Neuschmelting, David Reinecke, Niklas von Spreckelsen, Mitchel S. Berger, Shawn L. Hervey-Jumper, John G. Golfinos, Matija Snuderl, Sandra Camelo-Piragua, Christian Freudiger, Honglak Lee, Daniel A. Orringer
Molecular classification has transformed the management of brain tumors by enabling more accurate prognostication and personalized treatment. However, timely molecular diagnostic testing for patients with brain tumors is limited, complicating surgica
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7e78cc36b0b18ddc74878a4db8091d6d
http://arxiv.org/abs/2303.13610
http://arxiv.org/abs/2303.13610
Autor:
Todd Hollon, Cheng Jiang, Asadur Chowdury, Mustafa Nasir-Moin, Akhil Kondepudi, Alexander Aabedi, Arjun Adapa, Wajd Al-Holou, Jason Heth, Oren Sagher, Pedro Lowenstein, Maria Castro, Lisa Wadiura, Georg Widhalm, Volker Neuschmelting, David Reinecke, Niklas von Spreckelsen, Mitchell Berger, Shawn Hervey-Jumper, John Golfinos, Matija Snuderl, Sandra Camelo-Piragua, Christian Freudiger, Honglak Lee, Daniel Orringer
Molecular classification has transformed the management of brain tumors by enabling more accurate prognostication and personalized treatment. However, timely molecular diagnostic testing for brain tumor patients is limited [1–3], complicating surgi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::293d7eeed9c50c3d962c8af6e7b4d7e8
https://doi.org/10.21203/rs.3.rs-1930236/v1
https://doi.org/10.21203/rs.3.rs-1930236/v1